Rafael Holdings, Inc. (RFL) stock
RFLNYSEPharmaceutical PreparationsFiscal year ends July 31
$0.91−0.06 (-5.84%)
Close on Nov 17, 2026Market cap $47.67MP/E –Yield –
Rafael cash
Cash and short-term investments held at the end of each period.
Rafael's cash was $22.10M at Jul 31, 2026. For fiscal 2026 it was $22.10M, down 58.1% from the year before. Over ten years it grew 25.2% a year on average. The highest annual figure on record is $79.21M in fiscal 2023.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jul 31, 2026 | $22.10M | -58.1% |
| FY2025 | Jul 31, 2025 | $52.77M | -20.0% |
| FY2024 | Jul 31, 2024 | $65.94M | -16.8% |
| FY2023 | Jul 31, 2023 | $79.21M | +25.3% |
| FY2022 | Jul 31, 2022 | $63.24M | +391.9% |
| FY2021 | Jul 31, 2021 | $12.85M | +107.1% |
| FY2020 | Jul 31, 2020 | $6.21M | -48.4% |
| FY2019 | Jul 31, 2019 | $12.02M | -70.3% |
| FY2018 | Jul 31, 2018 | $40.50M | +244.5% |
| FY2017 | Jul 31, 2017 | $11.76M | +402.6% |
| FY2016 | Jul 31, 2016 | $2.34M | -58.6% |
| FY2015 | Jul 31, 2015 | $5.65M | – |
Quarterly cash
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jul 31, 2026 | $22.10M | -58.1% |
| Q3 FY2026CQ1 2026 | Apr 30, 2026 | $30.50M | -42.2% |
| Q2 FY2026CQ4 2025 | Jan 31, 2026 | $37.78M | -21.8% |
| Q1 FY2026CQ3 2025 | Oct 31, 2025 | $45.54M | -16.1% |
| Q4 FY2025CQ2 2025 | Jul 31, 2025 | $52.77M | -20.0% |
| Q3 FY2025CQ1 2025 | Apr 30, 2025 | $52.77M | -27.1% |
| Q2 FY2025CQ4 2024 | Jan 31, 2025 | $48.32M | -32.6% |
| Q1 FY2025CQ3 2024 | Oct 31, 2024 | $54.30M | +311.4% |
| Q4 FY2024CQ2 2024 | Jul 31, 2024 | $65.94M | -16.8% |
| Q3 FY2024CQ1 2024 | Apr 30, 2024 | $72.38M | -12.2% |
| Q2 FY2024CQ4 2023 | Jan 31, 2024 | $71.72M | -19.3% |
| Q1 FY2024CQ3 2023 | Oct 31, 2023 | $13.20M | -85.9% |
| Q4 FY2023CQ2 2023 | Jul 31, 2023 | $79.21M | +25.3% |
| Q3 FY2023CQ1 2023 | Apr 30, 2023 | $82.40M | +38.8% |
| Q2 FY2023CQ4 2022 | Jan 31, 2023 | $88.87M | +26.9% |
| Q1 FY2023CQ3 2022 | Oct 31, 2022 | $93.85M | +29.6% |
| Q4 FY2022CQ2 2022 | Jul 31, 2022 | $63.24M | +391.9% |
| Q3 FY2022CQ1 2022 | Apr 30, 2022 | $59.37M | +1168.9% |
| Q2 FY2022CQ4 2021 | Jan 31, 2022 | $70.03M | +1050.6% |
| Q1 FY2022CQ3 2021 | Oct 31, 2021 | $72.39M | +901.1% |
| Q4 FY2021CQ2 2021 | Jul 31, 2021 | $12.85M | +107.1% |
| Q3 FY2021CQ1 2021 | Apr 30, 2021 | $4.68M | -44.5% |
| Q2 FY2021CQ4 2020 | Jan 31, 2021 | $6.09M | -36.1% |
| Q1 FY2021CQ3 2020 | Oct 31, 2020 | $7.23M | -32.9% |
| Q4 FY2020CQ2 2020 | Jul 31, 2020 | $6.21M | -48.4% |
| Q3 FY2020CQ1 2020 | Apr 30, 2020 | $8.43M | -35.0% |
| Q2 FY2020CQ4 2019 | Jan 31, 2020 | $9.52M | -35.5% |
| Q1 FY2020CQ3 2019 | Oct 31, 2019 | $10.77M | -64.3% |
| Q4 FY2019CQ2 2019 | Jul 31, 2019 | $12.02M | -70.3% |
| Q3 FY2019CQ1 2019 | Apr 30, 2019 | $12.97M | -68.8% |
| Q2 FY2019CQ4 2018 | Jan 31, 2019 | $14.77M | +23.0% |
| Q1 FY2019CQ3 2018 | Oct 31, 2018 | $30.15M | +161.7% |
| Q4 FY2018CQ2 2018 | Jul 31, 2018 | $40.50M | +244.5% |
| Q3 FY2018CQ1 2018 | Apr 30, 2018 | $41.55M | +254.2% |
| Q2 FY2018CQ4 2017 | Jan 31, 2018 | $12.01M | +1.2% |
| Q1 FY2018CQ3 2017 | Oct 31, 2017 | $11.52M | +392.5% |
| Q4 FY2017CQ2 2017 | Jul 31, 2017 | $11.76M | – |
| Q3 FY2017CQ1 2017 | Apr 30, 2017 | $11.73M | – |
| Q2 FY2017CQ4 2016 | Jan 31, 2017 | $11.86M | – |
| Q4 FY2016CQ2 2016 | Jul 31, 2016 | $2.34M | – |
See a number that looks wrong?